Title : Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching - Kim_2022_Vascul.Pharmacol__107086 |
Author(s) : Kim SA , Lee AS , Lee HB , Hur HJ , Lee SH , Sung MJ |
Ref : Vascul Pharmacol , :107086 , 2022 |
Abstract : Kim_2022_Vascul.Pharmacol__107086 |
ESTHER : Kim_2022_Vascul.Pharmacol__107086 |
PubMedSearch : Kim_2022_Vascul.Pharmacol__107086 |
PubMedID: 35752378 |
Kim SA, Lee AS, Lee HB, Hur HJ, Lee SH, Sung MJ (2022)
Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching
Vascul Pharmacol
:107086
Kim SA, Lee AS, Lee HB, Hur HJ, Lee SH, Sung MJ (2022)
Vascul Pharmacol
:107086